Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- ;
- RMIT University
- ; University of Southampton
- University of Oslo
- ; University of Hertfordshire
- ; University of Warwick
- Academic Europe
- CK-CARE AG
- Christine Kühne – Center for Allergy Research and Education (CK-CARE)
- Heidelberg University
- Ilya Pharma
- Johannes Gutenberg University Mainz •
- Karolinska Institutet
- Leibniz
- Leiden University Medical Center (LUMC)
- Linköping University
- Radboud University Medical Center (Radboudumc)
- Stockholm University
- TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz •
- Technical University of Munich
- University Medical Centre Groningen (UMCG)
- University of Basel
- iBET - Instituto de Biologia Experimental e Tecnológica
- 13 more »
- « less
-
Field
-
within key immune cells among patients at different stages of atopic dermatitis and throughout the course of immunotherapy. The candidate will apply a variety of cellular, epigenomic and single cell
-
unknown chemokine can be used when developing next generation immunotherapies. Requirements Research FieldMedical sciencesEducation LevelMaster Degree or equivalent Skills/Qualifications Profile We
-
biomarkers, recurrence prediction, immunotherapy treatment response prediction and other various applications. In this research, you are expected to develop novel methods for cancer data modelling and analysis
-
patients. Imaging characteristics of H3K27M-mutant gliomas and biomarkers for response to T cell-based immunotherapies will be analyzed in orthotopic patient-derived tumor models and clinical cohorts
-
TRON – Translationale Oncology Oncology at the University Medical Center of the Johannes Gutenberg University Mainz • | Mainz, Rheinland Pfalz | Germany | about 11 hours ago
(Translational Oncology Mainz) are leading institutions in the field of immunotherapy. Our joint international PhD programme is looking for talented, junior researchers of all nationalities. Our ATLAS (Talent
-
Signals in Cancer” (Head: Prof. Dr. med. Jürgen Ruland) is to (i) explore the molecular mechanisms and pathways that drive immune dysfunction and immunotherapy resistance, (ii) modulate cancer
-
expression of key molecules that may be important to ovarian cancer immunotherapy and have wider implications for the treatment of chronic disease. Hypothesis: Xanthatin and/or carnosine modulate anti-cancer
-
criteria: Interest in and ability to work in an interdisciplinary setting, including with scientists and/or engineers. Experience in metallo-compound, cancer or immunotherapy research. Current treatments
-
/Media/Sports. TransMed plays a multifaceted role. It serves as the graduate school of the Research Centre "Translational Medicine" with its three research areas "Immunotherapy", "Translational